PDF herunterladen
neuroreha 2025; 17(01): 16-24
DOI: 10.1055/a-2515-5986
Schwerpunkt

Demenzdiagnose mittels Biomarker – geht das?

Stefan Teipel
› Weitere Informationen
    Lizenzen und Reprints
Zoom Image
 Was genau umfasst die Syndromdiagnose Demenz? Quelle: © K. Oborny/Thieme


Publikationsverlauf

Artikel online veröffentlicht:
17. März 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Jessen F, Frolich L. ICD-11: Neurocognitive Disorders. Fortschr Neurol Psychiatr 2018; 86: 172-177
    Thieme ConnectPubMedSuche in Google Scholar
  • 2 American Psychiatric Association A. Diagnostic and statistical manual of mental disorders, DSM V. 5th. ed. Washington, DC, USA: American Psychiatric Publishing; 2013
    CrossrefSuche in Google Scholar
  • 3 Wyman-Chick KA, Chaudhury P, Bayram E. et al. Differentiating prodromal dementia with Lewy bodies from prodromal Alzheimerʼs disease: A pragmatic review for clinicians. Neurol Ther 2024; 13: 885-906
    CrossrefPubMedSuche in Google Scholar
  • 4 Rascovsky K, Hodges JR, Knopman D. et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011; 134: 2456-2477
    CrossrefPubMedSuche in Google Scholar
  • 5 Folstein MF, Folstein SE, McHugh PR. Mini-mental-state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198
    CrossrefPubMedSuche in Google Scholar
  • 6 Kalbe E, Kessler J, Calabrese P. et al. DemTect: A new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry 2004; 19: 136-143
    CrossrefPubMedSuche in Google Scholar
  • 7 Nasreddine ZS, Phillips NA, Bedirian V. et al The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society 2005; 53: 695-699 JGS53221 [pii]
    CrossrefPubMedSuche in Google Scholar
  • 8 Shulman KI, Shedletsky R, Silver IL. The challenge of time: Clock drawing and cognitive function in the elderly. Int J Geriatr Psychiatry 1986; 1: 135-140
    CrossrefSuche in Google Scholar
  • 9 Petersen RC, Doody R, Kurz A. et al. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58: 1985-1992
    CrossrefPubMedSuche in Google Scholar
  • 10 Dubois B, Feldman HH, Jacova C. et al Research criteria for the diagnosis of Alzheimerʼs disease: Revising the NINCDS-ADRDA criteria. Lancet Neurology 2007; 6: 734-746 S1474-4422(07)70178-3 [pii]
    CrossrefPubMedSuche in Google Scholar
  • 11 Barker MS, Gottesman RT, Manoochehri M. et al. Proposed research criteria for prodromal behavioural variant frontotemporal dementia. Brain 2022; 145: 1079-1097
    CrossrefPubMedSuche in Google Scholar
  • 12 Sperling RA, Aisen PS, Beckett LA. et al Toward defining the preclinical stages of Alzheimerʼs disease: Recommendations from the National Institute on Aging-Alzheimerʼs Association workgroups on diagnostic guidelines for Alzheimerʼs disease. Alzheimers Dement 2011; 7: 280-292 S1552-5260(11)00099-9 [pii]
    CrossrefPubMedSuche in Google Scholar
  • 13 Jack CR, Bennett DA, Blennow K. et al. NIA-AA Research Framework: Toward a biological definition of Alzheimerʼs disease. Alzheimers Dement 2018; 14: 535-562
    CrossrefPubMedSuche in Google Scholar
  • 14 Bohlken J, Kostev K. Diagnostic and prescription behavior of general practitioners and specialist physicians in patients with dementia in 2005 and 2015 in Germany. Psychiatr Prax 2018; 45: 154-159
    Thieme ConnectPubMedSuche in Google Scholar
  • 15 Lee JC, Kim SJ, Hong S. et al. Diagnosis of Alzheimerʼs disease utilizing amyloid and tau as fluid biomarkers. Exp Mol Med 2019; 51: 1-10
    CrossrefPubMedSuche in Google Scholar
  • 16 Dorey A, Perret-Liaudet A, Tholance Y. et al. Cerebrospinal fluid Abeta40 improves the interpretation of Abeta42 concentration for diagnosing Alzheimerʼs disease. Front Neurol 2015; 6: 247
    CrossrefPubMedSuche in Google Scholar
  • 17 Rostamzadeh A, Jessen F. Early detection of Alzheimerʼs disease and dementia prediction in patients with mild cognitive impairment: Summary of current recommendations. Nervenarzt 2020; 91: 832-842
    CrossrefPubMedSuche in Google Scholar
  • 18 Teipel SJ, Temp AGM, Lutz MW. Bayesian meta-analysis of phase 3 results of aducanumab, lecanemab, donanemab, and high-dose gantenerumab in prodromal and mild Alzheimerʼs disease. Alzheimers Dement (N Y) 2024; 10: e12454
    CrossrefPubMedSuche in Google Scholar
  • 19 Klunk WE, Engler H, Nordberg A. et al. Imaging brain amyloid in Alzheimerʼs disease with Pittsburgh Compound-B. Annals of Neurology 2004; 55: 306-319
    CrossrefPubMedSuche in Google Scholar
  • 20 Villemagne VL, Pike KE, Chetelat G. et al. Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease. Annals of Neurology 2011; 69: 181-192
    CrossrefPubMedSuche in Google Scholar
  • 21 Teipel S, Tang Y, Boccardi M. Predicting cognitive decline in older people by structural and molecular imaging. Curr Opin Neurol 2023; 36: 253-263
    CrossrefPubMedSuche in Google Scholar
  • 22 Teipel SJ, Spottke A, Boecker H. et al. Patient-related benefits of amyloid PET imaging in dementia: Rationale and design of the German randomized coverage with evidence development study ENABLE. Alzheimers Dement (N Y) 2023; 9: e12383
    CrossrefPubMedSuche in Google Scholar
  • 23 Zhu L, Zhao W, Chen J. et al. Systematic review and meta-analysis of diagnostic test accuracy (DTA) studies: The role of cerebral perfusion imaging in prognosis evaluation of mild cognitive impairment. Ann Palliat Med 2022; 11: 673-683
    CrossrefPubMedSuche in Google Scholar
  • 24 Smailagic N, Lafortune L, Kelly S. et al. 18F-FDG PET for prediction of conversion to Alzheimerʼs disease dementia in people with mild cognitive impairment: An updated systematic review of test accuracy. J Alzheimers Dis 2018; 64: 1175-1194
    CrossrefPubMedSuche in Google Scholar
  • 25 Lombardi G, Crescioli G, Cavedo E. et al. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimerʼs disease in people with mild cognitive impairment. Cochrane Database Syst Rev 2020; 3: CD009628
    CrossrefPubMedSuche in Google Scholar
  • 26 Li H, Habes M, Wolk DA. et al. A deep learning model for early prediction of Alzheimerʼs disease dementia based on hippocampal magnetic resonance imaging data. Alzheimers Dement 2019; 15: 1059-1070
    CrossrefPubMedSuche in Google Scholar
  • 27 Palmqvist S, Tideman P, Cullen N. et al. Prediction of future Alzheimerʼs disease dementia using plasma phospho-tau combined with other accessible measures. Nature Medicine 2021; 27: 1034-1042
    CrossrefPubMedSuche in Google Scholar
  • 28 Devanarayan V, Doherty T, Charil A. et al. Plasma pTau217 predicts continuous brain amyloid levels in preclinical and early Alzheimerʼs disease. Alzheimers Dement 2024; 20: 5617-5628
    CrossrefPubMedSuche in Google Scholar
  • 29 Zhang S, Smailagic N, Hyde C. et al. (11)C-PIB-PET for the early diagnosis of Alzheimerʼs disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev 2014; 7: CD010386
    CrossrefPubMedSuche in Google Scholar
  • 30 Martinez G, Vernooij RW, Fuentes Padilla P. et al. 18F PET with flutemetamol for the early diagnosis of Alzheimerʼs disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev 2017; 11: CD012884
    CrossrefPubMedSuche in Google Scholar
  • 31 Martinez G, Vernooij RW, Fuentes Padilla P. et al. 18F PET with florbetapir for the early diagnosis of Alzheimerʼs disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev 2017; 11: CD012216
    CrossrefPubMedSuche in Google Scholar
  • 32 Martinez G, Vernooij RW, Fuentes Padilla P. et al. 18F PET with florbetaben for the early diagnosis of Alzheimerʼs disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev 2017; 11: CD012883
    CrossrefPubMedSuche in Google Scholar
  • 33 Ruan D, Sun L. Amyloid-beta PET in Alzheimerʼs disease: A systematic review and Bayesian meta-analysis. Brain Behav 2023; 13: e2850
    CrossrefPubMedSuche in Google Scholar